These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31340240)

  • 21. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
    Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen therapy in women, beyond libido.
    Davis SR
    Climacteric; 2013 Aug; 16 Suppl 1():18-24. PubMed ID: 23647457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global Consensus Position Statement on the Use of Testosterone Therapy for Women.
    Davis SR; Baber R; Panay N; Bitzer J; Perez SC; Islam RM; Kaunitz AM; Kingsberg SA; Lambrinoudaki I; Liu J; Parish SJ; Pinkerton J; Rymer J; Simon JA; Vignozzi L; Wierman ME
    J Sex Med; 2019 Sep; 16(9):1331-1337. PubMed ID: 31488288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of androgens in hormone replacement therapy.
    Johnson CE; Berman JR
    Expert Opin Pharmacother; 2005 Sep; 6(11):1815-31. PubMed ID: 16144503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of testosterone use in women.
    Shufelt CL; Braunstein GD
    Maturitas; 2009 May; 63(1):63-6. PubMed ID: 19250779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women.
    Jayasena CN; Alkaabi FM; Liebers CS; Handley T; Franks S; Dhillo WS
    Clin Endocrinol (Oxf); 2019 Mar; 90(3):391-414. PubMed ID: 30488972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone for the treatment of hypoactive sexual desire disorder: part II.
    Feldhaus-Dahir M
    Urol Nurs; 2009; 29(5):386-9, 378. PubMed ID: 19863046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg S
    J Sex Med; 2007 Mar; 4 Suppl 3():227-34. PubMed ID: 17394595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone therapy for postmenopausal women: efficacy and safety.
    Somboonporn W
    Semin Reprod Med; 2006 Apr; 24(2):115-24. PubMed ID: 16633985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. To be or not to be in sexual desire: the androgen dilemma.
    Nappi RE
    Climacteric; 2015 Oct; 18(5):672-4. PubMed ID: 26176767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies.
    Braunstein GD
    J Sex Med; 2007 Jul; 4(4 Pt 1):859-66. PubMed ID: 17627735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline.
    Wierman ME; Arlt W; Basson R; Davis SR; Miller KK; Murad MH; Rosner W; Santoro N
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3489-510. PubMed ID: 25279570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Inquiry: which treatments help women with reduced libido?
    Hobbs K; Handler L
    J Fam Pract; 2013 Feb; 62(2):102-3. PubMed ID: 23405381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global Consensus Position Statement on the Use of Testosterone Therapy for Women.
    Davis SR; Baber R; Panay N; Bitzer J; Perez SC; Islam RM; Kaunitz AM; Kingsberg SA; Lambrinoudaki I; Liu J; Parish SJ; Pinkerton J; Rymer J; Simon JA; Vignozzi L; Wierman ME
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4660-4666. PubMed ID: 31498871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global consensus statement on testosterone therapy for women: an Australian perspective.
    Jang C; Boyle JA; Vincent A
    Med J Aust; 2020 Nov; 213(10):449-452.e1. PubMed ID: 33131104
    [No Abstract]   [Full Text] [Related]  

  • 38. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
    El-Hage G; Eden JA; Manga RZ
    Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case series of androgen use in breast cancer survivors with sexual dysfunction.
    Krychman ML; Stelling CJ; Carter J; Hudis CA
    J Sex Med; 2007 Nov; 4(6):1769-74. PubMed ID: 17666036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of androgens for female sexual dysfunction.
    Davis SR
    Nat Clin Pract Urol; 2006 Apr; 3(4):176-7. PubMed ID: 16607352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.